Vanguard Pharmaceutical has received a 10 year exclusive sales contract from Arbro Pharmaceutical for the sale of its pharmaceutical products in Latin America and the Caribbean.
Subscribe to our email newsletter
Vanguard’s strategic alliance with Arbro is expected to ensure delivery of quality products at affordable prices.
Vanguard said that it has performed a market price analysis of Arbro’s drugs in Brazil, Peru, and Paraguay and has found their prices to be significantly lower than recent tenders granting it a huge opportunity in these countries.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.